Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

2017.04.10

U. Andreasson, K. Blennow, and H. Zetterberg, " Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders", Alzheimers Dement. 3:98-102 (2016).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941042/

Previous
Previous

Biosensing utilizing magnetic markers and superconducting quantum interference devices

Next
Next

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease